These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34476902)

  • 1. Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study.
    Pasta A; Borro P; Cremonini AL; Formisano E; Tozzi G; Cecchi S; Fresa R; Labanca S; Djahandideh A; Sukkar SG; Picciotto A; Pisciotta L
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00820. PubMed ID: 34476902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD.
    Carter A; Brackley SM; Gao J; Mann JP
    J Hepatol; 2019 Jan; 70(1):142-150. PubMed ID: 30315827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
    Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
    J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Form of Metabolic-Associated Fatty Liver Disease Associated with a Novel LIPA Variant.
    Anushiravani A; Jafari Khamirani H; Mohamadkhani A; Mani A; Dianatpour M; Malekzadeh R
    Arch Iran Med; 2023 Feb; 26(2):86-91. PubMed ID: 37543928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
    Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
    J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
    Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M
    World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
    Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
    Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Artery Disease-Associated
    Morris GE; Braund PS; Moore JS; Samani NJ; Codd V; Webb TR
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1050-1057. PubMed ID: 28279971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
    Maciejko JJ
    Am J Cardiovasc Drugs; 2017 Jun; 17(3):217-231. PubMed ID: 28197978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
    Baratta F; Pastori D; Polimeni L; Tozzi G; Violi F; Angelico F; Del Ben M
    Int J Mol Sci; 2015 Nov; 16(12):28014-21. PubMed ID: 26602919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase.
    Bradić I; Liesinger L; Kuentzel KB; Vujić N; Trauner M; Birner-Gruenberger R; Kratky D
    J Lipid Res; 2023 Sep; 64(9):100427. PubMed ID: 37595802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of LIPA gene polymorphisms with obesity-related metabolic complications among severely obese patients.
    Guénard F; Houde A; Bouchard L; Tchernof A; Deshaies Y; Biron S; Lescelleur O; Biertho L; Marceau S; Pérusse L; Vohl MC
    Obesity (Silver Spring); 2012 Oct; 20(10):2075-82. PubMed ID: 22395809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency.
    Santillán-Hernández Y; Almanza-Miranda E; Xin WW; Goss K; Vera-Loaiza A; Gorráez-de la Mora MT; Piña-Aguilar RE
    World J Gastroenterol; 2015 Jan; 21(3):1001-8. PubMed ID: 25624737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency.
    Del Angel G; Hutchinson AT; Jain NK; Forbes CD; Reynders J
    Hum Mutat; 2019 Nov; 40(11):2007-2020. PubMed ID: 31180157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights.
    Cappuccio G; Donti TR; Hubert L; Sun Q; Elsea SH
    J Inherit Metab Dis; 2019 May; 42(3):509-518. PubMed ID: 30684275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.
    Poinsot P; Collardeau Frachon S; Restier L; Sérusclat A; Di Filippo M; Charrière S; Moulin P; Lachaux A; Peretti N
    J Clin Lipidol; 2017; 11(1):167-177.e3. PubMed ID: 28391883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease.
    Tovoli F; Napoli L; Negrini G; D'Addato S; Tozzi G; D'Amico J; Piscaglia F; Bolondi L
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease.
    Ferri F; Mischitelli M; Tozzi G; Messina E; Mignini I; Mazzuca S; Pellone M; Parisse S; Marrapodi R; Visentini M; Baratta F; Del Ben M; Pastori D; Perciballi R; Attilia ML; Carbone M; De Santis A; Violi F; Angelico F; Ginanni Corradini S
    Clin Transl Gastroenterol; 2020 Feb; 11(2):e00116. PubMed ID: 32463622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
    Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
    Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lysosomal acid lipase overexpression worsens hepatic inflammation in mice fed a Western diet.
    Lopresti MW; Cui W; Abernathy BE; Fredrickson G; Barrow F; Desai AS; Revelo XS; Mashek DG
    J Lipid Res; 2021; 62():100133. PubMed ID: 34624333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.